Recent advances in the management of hepatocellular carcinoma

Liver cancer remains a challenge of global health, being the 4th leading cause of cancer death worldwide. Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, and is usually precipitated by chronic viral infections (hepatitis B and C), non-alcoholic steatohepatitis, heavy...

Full description

Saved in:

Bibliographic Details
Published in:	Clinical and Molecular Hepatology Vol. 30; no. 1; pp. 1 - 15
Main Authors:	Sankar, Kamya, Gong, Jun, Osipov, Arsen, Miles, Steven A., Kosari, Kambiz, Nissen, Nicholas N., Hendifar, Andrew E., Koltsova, Ekaterina K., Yang, Ju Dong
Format:	Journal Article
Language:	English
Published:	Korea (South) The Korean Association for the Study of the Liver 01.01.2024 Korean Association for the Study of the Liver 대한간학회
Subjects:	Ablation Cancer therapies Carcinoma Carcinoma, Hepatocellular - etiology Carcinoma, Hepatocellular - therapy Diseases of the digestive system. Gastroenterology FDA approval Hepatitis B Hepatitis B - complications Hepatitis C Hepatocellular Hepatocellular carcinoma Humans Immunotherapy Kinases Liver cancer Liver Cirrhosis Liver Cirrhosis - complications Liver Neoplasms Liver Neoplasms - complications Liver transplants Medical prognosis RC799-869 Response rates Review Tyrosine protein kinase inhibitors 내과학 United States > US Liver cancer Hepatocellular carcinoma Tyrosine protein kinase inhibitors Immunotherapy
ISSN:	2287-2728, 2287-285X, 2287-285X
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!